sq-11725 has been researched along with Alcoholic Cirrhosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angeli, P; Bellini, B; Bernardinello, E; Bolognesi, M; Cavallarin, G; Donada, C; Felder, M; Gatta, A; Marin, R; Merkel, C; Torboli, P; Zanella, P | 1 |
| Laleman, W; Nevens, F | 1 |
| Campanati, L; Di Mauro, P; Gridelli, B; Langer, M; Peta, M; Pezzi, A; Pifferi, S; Prato, P; Proietti, D; Quarenghi, E | 1 |
| Calès, P; Ideo, G; Lebrec, D; Pagliaro, L; Pascal, JP; Pasta, L; Poynard, T | 1 |
2 review(s) available for sq-11725 and Alcoholic Cirrhosis
| Article | Year |
|---|---|
Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding.
Topics: Adrenergic beta-Antagonists; Animals; Contraindications; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Follow-Up Studies; Forecasting; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Middle Aged; Nadolol; Portasystemic Shunt, Surgical; Portasystemic Shunt, Transjugular Intrahepatic; Practice Guidelines as Topic; Propranolol; Randomized Controlled Trials as Topic; Rats; Risk Factors; Risk Reduction Behavior; Splanchnic Circulation; Stents; Time Factors; Vascular Resistance; Vasodilator Agents | 2006 |
Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter
Topics: Adrenergic beta-Antagonists; Ascites; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Meta-Analysis as Topic; Middle Aged; Nadolol; Prognosis; Propranolol | 1991 |
3 trial(s) available for sq-11725 and Alcoholic Cirrhosis
| Article | Year |
|---|---|
A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis.
Topics: Adrenergic beta-Antagonists; Aged; Disease-Free Survival; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Nadolol; Placebos | 2004 |
Beta-adrenergic antagonists to prevent bleeding from esophageal varices: a risk during liver transplantation?
Topics: Adult; Cardiac Output; Esophageal and Gastric Varices; Female; Heart Rate; Hemorrhage; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Transplantation; Male; Middle Aged; Monitoring, Intraoperative; Nadolol; Oxygen; Propranolol; Risk Factors | 1994 |
Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter
Topics: Adrenergic beta-Antagonists; Ascites; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Meta-Analysis as Topic; Middle Aged; Nadolol; Prognosis; Propranolol | 1991 |